Jump to ContentJump to Main Navigation
Show Summary Details


1 Issue per year


Emerging Science

Open Access

    Open Access
    See all formats and pricing
    More options …


    "OncomiRs" is closed for submissions effective September 1, 2013. It has been merged with "microRNA Diagnostics and Therapeutics". All authors are therefore invited to submit manuscripts at http://www.degruyter.com/view/j/micrnat.

    OncomiRs is an international, peer-reviewed, open-access journal that welcomes original research relevant to the interdisciplinary nature of microRNAs and cancer biology. As a central place of communication for the field community, the journal aspires to facilitate the sharing and dissemination of significant contributions and timely research in the emerging field of microRNAs in cancer. The journal publishes original research articles and reviews covering all the basics aspects of the microRNAs implication in tumor formation and development as well as their role in the treatment sensitivity and resistance. The OncomiRs journal focuses on the basic principles of microRNAs implication in the regulation of cellular processes like apoptosis, cell cycle control, metastatic dissemination, cellular senescence and immortalization. A particular attention is given to microRNA-controled regulation of cellular oncogenes and tumor suppressor genes.

    CrossCheck Plagiarism Screening System

    The editorial board is participating in a growing community of CrossCheck System's users in order to ensure that the content published is original and trustworthy. CrossCheck is a medium that allows for comprehensive manuscripts screening, aimed to eliminate plagiarism and provide a high standard and quality peer-review process.

    Detailed description of the CrossCheck System can be found at:

    Aims and Scope

    Why subscribe and read

    The OncomiRs journal creates a unique, central communication place for all members of the researcher community working on microRNAs biology and cancer research. It centralizes the most exciting new discoveries of the field by giving a completely free access to publication to both authors and readers.


    Emerging Science
    Type of Publication:

    Submission of Manuscripts

    More ...

    Abstracting & Indexing

    OncomiRs is covered by the following services:

    • Baidu Scholar
    • Case
    • Celdes
    • CNKI Scholar (China National Knowledge Infrastructure)
    • CNPIEC
    • EBSCO Discovery Service
    • Genamics JournalSeek
    • Google Scholar
    • J-Gate
    • JournalTOCs
    • KESLI-NDSL (Korean National Discovery for Science Leaders)
    • Meta (formerly Sciencescape)
    • Naviga (Softweco)
    • Primo Central (ExLibris)
    • Publons
    • PubsHub
    • ReadCube
    • ResearchGate
    • Sherpa/RoMEO
    • Summon (Serials Solutions/ProQuest)
    • TDNet
    • Ulrich's Periodicals Directory/ulrichsweb
    • WanFang Data
    • WorldCat (OCLC)

    Editorial Information

    Journal Editor
    Benjamin Ory, Nantes University School of Medicine, France

    Editorial Advisory Board
    George Adrian Calin, University of Texas MD Anderson Cancer Center, USA
    William C.S. Cho, Queen Elizabeth Hospital, China
    Aurora Esquela-Kerscher, Eastern Virginia Medical School, USA
    Elsa Flores, University of Texas MD Anderson Cancer Center, USA
    Adrian Harris, University of Oxford, United Kingdom
    Clark Jeffries, University of North Carolina at Chapel Hill, USA
    Jingfang Ju, Stony Brook University Medical Center, USA
    Hannele Ruohola-Baker, University of Washington, USA
    Raymond Schiffelers, UMC Utretch, The Netherlands
    Bruce A. White, University of Connecticut Health Center, USA 

    Assistant Editors
    Marc Baud’huin, Nantes University School of Medicine, France
    Francois Lamoureux, Nantes University School of Medicine, France
    Lidia Rodriguez Calleja, Nantes University School of Medicine, France 

    Language Editors
    Douangsone D. Vadysirisack, Harvard University, USA

    Benjamin Ory

    Versita Ltd.
    ul. Solipska 14a/1
    02-482 Warsaw, Poland
    Phone: +48 22 701 50 15

    Comments (0)

    Please log in or register to comment.
    Log in